Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Leukaemia Drug Could Help Treat Breast Cancer

Published: Friday, August 23, 2013
Last Updated: Thursday, August 22, 2013
Bookmark and Share
A drug currently used to treat leukaemia might also help prevent breast cancer from spreading to other parts of the body.

The discovery could also pave the way for improved early diagnostics.

Peter Storz and colleagues tested the drug, decitabine, in a mouse model of breast cancer where it shrank the primary breast tumour and minimised metastasis to the animals' lungs. Mice treated with drug had very few or no metastases in their lungs, and those that were found were around 40 times smaller than those observed in untreated control animals. Decitabine, or drugs that work in a similar way, could be used to help manage breast cancer, the authors say, but human studies will be needed.

The drug works by targeting a particular gene, called PRKD1. Normally, the gene is switched on, but in invasive breast cancer, gene-inactivating molecules called methyl groups bind to the DNA next to the gene, switching it off. Decitabine prevents these methyl groups from binding to DNA.

Treatment with the drug reduced methylation levels around the PRKD1 gene. As a result, the gene was switched back on, and was able to start churning out protein as normal.

The authors also studied methylation levels in human breast cancer tissues with varying degrees of invasiveness. Methylation levels correlated with the cancer's potential to spread. The finding could, the authors say, be used to help generate a new diagnostic test that could predict how likely breast cancer is to metastasize.

Decitabine is one of a handful of FDA-approved cancer drugs that work via epigenetics, influencing the structure and form of DNA to affect gene expression, without altering the DNA sequence itself. Alongside genetic changes, epigenetic differences are now known to play a role in many different types of tumour, including prostate and cervical cancer. Decitabine is currently licensed for the treatment of acute myeloid leukaemia, a cancer of white blood cells.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Imaging Software Could Speed Up Breast Cancer Diagnosis
Researchers use high speed optical microscopy of intact breast tissue specimens to analyze breast tissue.
Friday, August 21, 2015
Detecting and Identifying Candida Species in Blood Samples of Critically Ill Paediatric Patients
The study aimed to develop a multiplex nested PCR method to detect and identify seven Candida species in peripheral blood samples of critically ill paediatric patients.
Wednesday, August 27, 2014
Researchers Identify Urgent Need for Alzheimer's Disease Drug Development
Analysis of clinical trials published in the journal Alzheimer's Research & Therapy shows that the pipeline for potential treatments of AD is small and rate of success is limited.
Friday, July 04, 2014
Showing Your Age: Your DNA Doesn't Lie
Using thousands of tissue samples from open access datasets, a scientist has created a calculator which predicts the age of tissue using chemical changes to DNA.
Monday, October 21, 2013
No Place to Hide: Evolutionary Forensics
The rapid molecular evolution of hepatitis C virus (HCV) has been used to help incriminate the source of an outbreak in two Spanish hospitals in the late nineties.
Monday, July 29, 2013
A Possible Blood Test for Alzheimer’s Disease
A new blood test can be used to discriminate between people with Alzheimer's disease and healthy controls.
Monday, July 29, 2013
Is Enough Being Done to Make Drinking Water Safe?
Arsenic in water is threatening the lives of several hundred million people.
Monday, June 03, 2013
Women’s Immune Systems Remain Younger for Longer
The slower decline in a woman’s immune system may contribute to women living longer than men.
Wednesday, May 15, 2013
Testing the Water – Urine Test Identifies Babies at Most Risk of Necrotizing Enterocolitis
Abnormal gut bacteria in premature babies can be found days before the onset of necrotizing enterocolitis (NEC) finds new research in BioMed Central’s open access journal Microbiome.
Tuesday, April 16, 2013
Gene Signature Can Predict Who Will Survive Chemotherapy
An eight gene ‘signature’ can predict length of relapse-free survival after chemotherapy, finds new research in Biomed Central’s open access journal BMC Medicine.
Tuesday, April 16, 2013
The Tulip Tree Reveals Mitochondrial Genome of Ancestral Flowering Plant
The extraordinary level of conservation of the tulip tree mitochondrial genome has redefined our interpretation of evolution of the angiosperms (flowering plants).
Tuesday, April 16, 2013
Organizing Human Specimen Collections: Getting the Best out of Biobanks
The diversity of biobanks, collections of human specimens from a variety of sources, raises questions about the best way to manage and govern them.
Friday, March 22, 2013
Oxygen-Free Energy Designed to Fuel Brain Development Spurs on Growth of Cancer
The metabolic process which fuels the growth of many cancers has its origins in normal brain growth finds a new study published in BioMed Central's open access journal Cancer & Metabolism.
Wednesday, January 23, 2013
What Did Our Ancestors Look Like?
A new method of establishing hair and eye colour from modern forensic samples can also be used to identify details from ancient human remains.
Monday, January 14, 2013
Microevolutionary Analysis of C. difficile Genomes to Investigate Transmission
Recent study took a genomics approach to assess the incidence of patient-to-patient transmission of C. difficile.
Thursday, January 03, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos